Skip to Content
Merck
CN
All Photos(1)

Documents

AB9279

Sigma-Aldrich

Anti-Rhodopsin Antibody

Chemicon®, from rabbit

Sign Into View Organizational & Contract Pricing

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41

biological source

rabbit

Quality Level

antibody form

affinity purified immunoglobulin

antibody product type

primary antibodies

clone

polyclonal

purified by

affinity chromatography

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunohistochemistry: suitable (paraffin)

NCBI accession no.

UniProt accession no.

shipped in

dry ice

target post-translational modification

unmodified

Gene Information

human ... RHO(6010)

Specificity

Recognizes Rhodopsin.

Immunogen

Synthetic peptide from the 2nd extracellular domain of human Rhodopsin.

Application

Anti-Rhodopsin Antibody detects level of Rhodopsin & has been published & validated for use in IH(P).
Immunohistochemistry on paraffin embedded tissue sections.

Optimal working dilutions must be determined by the end user.
Research Category
Neuroscience
Research Sub Category
Sensory & PNS

Physical form

Affinity purified immunoglobulin. Liquid in PBS, with less than 0.1% sodium azide.

Storage and Stability

Maintain at -70°C in undiluted aliquots for up to 6 months after date of receipt. Avoid repeated freeze/thaw cycles.

Other Notes

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Riccardo Natoli et al.
Molecular vision, 24, 201-217 (2018-03-13)
Systemic increases in reactive oxygen species, and their association with inflammation, have been proposed as an underlying mechanism linking obesity and age-related macular degeneration (AMD). Studies have found increased levels of oxidative stress biomarkers and inflammatory cytokines in obese individuals;
Riccardo Natoli et al.
Investigative ophthalmology & visual science, 58(7), 2977-2990 (2017-06-13)
Complement system dysregulation is strongly linked to the progression of age-related macular degeneration (AMD). Deposition of complement including C3 within the lesions in atrophic AMD is thought to contribute to lesion growth, although the contribution of local cellular sources remains
Kristin L Gardiner et al.
Molecular therapy : the journal of the American Society of Gene Therapy, 28(1), 266-278 (2019-10-13)
The form of hereditary childhood blindness Leber congenital amaurosis (LCA) caused by biallelic RPE65 mutations is considered treatable with a gene therapy product approved in the US and Europe. The resulting vision improvement is well accepted, but long-term outcomes on
Isabel Pinilla et al.
Experimental eye research, 150, 122-134 (2015-11-03)
To characterize the relationship between fundus autofluorescence (FAF), Optical Coherence Tomography (OCT) and immunohistochemistry (IHC) over the course of chronic retinal degeneration in the P23H rat. Homozygous albino P23H rats, Sprague-Dawley (SD) rats as controls and pigmented Long Evans (LE)
Ricardo Usategui-Martín et al.
Investigative ophthalmology & visual science, 63(4), 27-27 (2022-04-30)
Degenerative mechanisms of retinal neurodegenerative diseases (RND) share common cellular and molecular signalization pathways. Curative treatment does not exist and cell-based therapy, through the paracrine properties of mesenchymal stem cells (MSC), is a potential unspecific treatment for RND. This study

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service